share_log

Centessa Pharmaceuticals Q4 EPS $(0.38) Beats $(0.48) Estimate

Benzinga ·  Mar 28 16:56

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.48) by 20.83 percent. This is a 15.56 percent increase over losses of $(0.45) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment